Albumin
Albumins unique properties offer unlimited potential in the field of medical science.
Learn moreThe current global pandemic has shined a light on the importance of diagnostic testing, especially for COVID-19. As the coronavirus continues to sweep across the globe, it has never been more vital to focus efforts on identifying those infected with the disease to delay and halt the spread of infection. A coordinated effort is needed to accelerate research and, whilst vaccine roll-out is still only in the early stages, the world is more cognizant of how reliable diagnostic testing is a valuable tool to save lives.
Read moreAlbumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced today the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan.
Read moreApproximately one month ago our American Business Development Directors, Gary Willingham and Brian MacDonald, participated in the virtual American Drug Delivery and Formulation Summit. Albumedix has been a long-standing supporter of both the American and European DDF Summits and as such, we always look forward to catching up with collaborators and industry partners - although this time virtually.
Read moreDid you know that unlike other recombinant human albumin manufacturers, Albumedix are so much more than simply ‘an albumin supplier’? When you work with us, you also get access to 100 brilliant minds behind the vial, including a dedicated Business Development Director responsible for managing your account.
Read moreLast week, our CEO (Jonas Skjødt Møller) participated in a virtual strategy panel discussion at the Bio Integrates 2020 conference to discuss the still urgently pressing issue on how to overcome the apparent scalability and health economic challenges associated with advanced therapies. Speaking in the panel was other experts from within the field, including:
Read moreAcknowledging the "tumultuous year" 2020 has proven to be, PharmaVOICE recently pulled together an interesting review piece, featuring input from several industry experts such as Albumedix CEO; Jonas S. Møller.
Read moreIn a constant effort to understand the use of albumin and the market needs, we would appreciate your feedback in this short product format survey. If you have a few minutes spare to provide your opinion, we can continue to adapt our product offering to ensure you have exactly what you need to make your therapy safe, successful & out to market quickly.
Read moreWith the number of new medical devices being developed at an all-time high and commercial successes making global headline news, the industry is booming. But this promising growth comes with underlying challenges.
Read moreMeet Dangerous Dave Phillipson; a formidable, Nottingham based, three-time Paralympian in tennis who took to the water in 2017 and is now paracanoeing his way to Tokyo 2021.
Read moreMeet Helen Rawsthorne. Helen is a Senior Research Scientist within Albumedix and a truly brilliant example of our many brilliant minds. Presently in her 7th year working for the company, the following interview will take you through Helen's background, her role within Albumedix and give you a sneak preview into what our Technical Group get up to in the day.
Read moreAs cutting-edge drugs such as viral vectors, cancer vaccines and oncolytic virotherapies make their way through the development pipeline, medical science stands on the brink of an unseen revolution. However, the life-changing potential of such innovative, virus-based therapies is not without challenges.
Read moreAlbumedix, the world leader in recombinant human albumin, announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020. This announcement follows the recent appointment of Jonas Skjødt Møller as Chief Executive Officer of Albumedix and is part of the company’s global growth strategy.
Read moreIncrease cell performance; address logistical challenges with an optimized cryopreservation solution as presented by Phil Morton, Chief Technology Officer within Albumedix
Read moreAlbumedix are thrilled to be able to continue supporting the Nottinghamshire Wildlife Trust in their endeavours to protect and restore the beautiful environment and wildlife both on our doorstep and across the region.
Read moreAlbumedix is a world leading manufacturer of recombinant human albumin (rHA), and as such our manufacturing plant is the core of our business. As a company, we talk a lot about our rHA products, how they’re useful in different applications and what benefits they can bring to final therapies for patients worldwide. However, we don’t talk as much about the amazing people within our business that make the magic happen.
Read moreIn December, Albumedix held a 'Capping off Ceremony' to celebrate the brand new, four-storey manufacturing plant extension being confirmed as watertight!
Read more